These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro. Edwards G; Henshaw M; Miller M; Weston AH Br J Pharmacol; 1991 Mar; 102(3):679-86. PubMed ID: 1364839 [TBL] [Abstract][Full Text] [Related]
9. Effects of K+ channel openers on the vascular actions of human gamma globulin. Abrahams Z; Sutter MC Eur J Pharmacol; 1994 Feb; 252(2):195-203. PubMed ID: 7512504 [TBL] [Abstract][Full Text] [Related]
10. The electrophysiological effects of tetraphenylphosphonium on vascular smooth muscle. Zhang H; Bolton TB; Piekarska AE; McPherson GA Eur J Pharmacol; 1998 Apr; 347(1):119-23. PubMed ID: 9650857 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide. Quast U; Cook NS J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478 [TBL] [Abstract][Full Text] [Related]
12. Effects of the potassium channel openers KRN4884 and levcromakalim on the contraction of rat aorta induced by A23187, compared with nifedipine. Kawahara J; Izumi H; Okada Y; Izawa T Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):460-5. PubMed ID: 8897449 [TBL] [Abstract][Full Text] [Related]
13. Effects of aranidipine, a novel calcium channel blocker, on mechanical responses of the isolated rat portal vein: comparison with typical calcium channel blockers and potassium channel openers. Okumura K; Ichihara K; Nagasaka M J Cardiovasc Pharmacol; 1997 Feb; 29(2):209-15. PubMed ID: 9057070 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of 2,3,4a,11b-tetrahydro-oxazino[2,3-c]benzopyran-9-carbonitriles as ATP-sensitive potassium channel openers. Cheng CY; Chiu HI; Chang MJ; Lin YC; Tsai MC; Yu HC Bioorg Med Chem Lett; 1998 Mar; 8(5):463-8. PubMed ID: 9871599 [TBL] [Abstract][Full Text] [Related]
15. Potassium channel opening properties of a novel compound, NIP-121, cromakalim and nicorandil in rat aorta and portal vein. Masuda Y; Arakawa C; Yamashita T; Miyajima M; Shigenobu K; Kasuya Y; Tanaka S Eur J Pharmacol; 1991 Apr; 195(3):323-31. PubMed ID: 1831135 [TBL] [Abstract][Full Text] [Related]
16. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle. Perez-Vizcaino F; Casis O; Rodriguez R; Gomez LA; Garcia Rafanell J; Tamargo J Br J Pharmacol; 1993 Nov; 110(3):1165-71. PubMed ID: 8298804 [TBL] [Abstract][Full Text] [Related]
17. Two types of ATP-sensitive potassium channels in rat portal vein smooth muscle cells. Zhang HL; Bolton TB Br J Pharmacol; 1996 May; 118(1):105-14. PubMed ID: 8733582 [TBL] [Abstract][Full Text] [Related]
18. Propafenone modulates potassium channel activities of vascular smooth muscle from rat portal veins. Cogolludo AL; Pérez-Vizcaíno F; López-López G; Ibarra M; Zaragozá-Arnáez F; Tamargo J J Pharmacol Exp Ther; 2001 Nov; 299(2):801-10. PubMed ID: 11602697 [TBL] [Abstract][Full Text] [Related]
19. Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta. Uchida W; Hirano Y; Shirai Y; Taguchi T; Masuda N; Shibasaki K; Hirano S; Matsumoto Y; Tsuzuki R; Yanagisawa I Arch Int Pharmacodyn Ther; 1994; 327(3):330-43. PubMed ID: 7848015 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the vascular relaxant effects of ATP-dependent K+ channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats. Kwan YW; To KW; Lau WM; Tsang SH Eur J Pharmacol; 1999 Jan; 365(2-3):241-51. PubMed ID: 9988108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]